Streetbeat News

Analyst Ratings

VKTX

Viking Therapeutics (NASDAQ:VKTX) has received positive analyst ratings in the last quarter, with 7 bullish and 4 somewhat bullish ratings. The average price target for the stock is $33.36, a significant increase from the current price of $14.4966. This average has increased by 19.14% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

EQIX

Truist Securities analyst Anthony Hau has downgraded Equinix, Inc. (NASDAQ:EQIX) from Buy to Hold, and lowered the price target to $815 from $870. The analyst anticipates a deceleration in adjusted funds from operations (AFFO) earnings growth in 2024 due to various factors. There is potential for EQIX to grow into its valuation multiple, but the analyst believes there is a greater downside risk to the valuation.

Portfolio Pulse from Nabaparna Bhattacharya

June 27, 2023 | 5:56 pm

ACET

BDTX

CNTG

RIDE

SYTA

TIVC

WBA

Several stocks experienced significant movement in Tuesday's mid-day session. Notable gainers included Tivic Health Systems, Black Diamond Therapeutics, and Centogene, which saw increases due to distribution agreements, promising clinical data, and joint ventures respectively. On the other hand, Adicet Bio, Siyata Mobile, and Lordstown Motors Corp were among the biggest losers, with drops due to disappointing clinical data, share offerings, and bankruptcy filings respectively. Walgreens Boots Alliance also saw a decrease after lowering its FY23 guidance.

Portfolio Pulse from Lisa Levin

June 27, 2023 | 5:56 pm

BDTX

Traders are circulating a note from Cowen that highlights data from Black Diamond Therapeutics. The content of the note is not specified.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 5:52 pm

RCEL

Cantor Fitzgerald has initiated coverage on Avita Medical Inc (NASDAQ:RCEL) with an Overweight rating and a price target of $23. The analyst believes that Avita's RECELL system will disrupt traditional skin grafts, requiring significantly less donor skin. The system also reduces the number of autograft procedures and hospital stay length. The company can tap into an additional 10,000 annual burn procedures and approximately 110,000 acute wound procedures, suggesting a total addressable market (TAM) of $1.0 billion. Furthermore, an estimated 1.3 million stable vitiligo procedures in the U.S. indicate a potential TAM of $5.2 billion.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:51 pm

META

A significant number of investors have taken a bearish stance on Meta Platforms (NASDAQ:META), with 60% of detected trades showing bearish expectations. However, the stock price is up 3.16% at $287.27. Analysts from Roth MKM, Oppenheimer, Citigroup, JMP Securities, and UBS have maintained their positive ratings on Meta Platforms, with price targets ranging from $300 to $360.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:49 pm

PLTR

A significant amount of unusual options activity has been observed for Palantir Technologies (NYSE:PLTR), with a majority of investors taking a bullish stance. The trades include 4 puts amounting to $315,452 and 15 calls amounting to $596,044. The targeted price range for Palantir over the last 3 months has been between $7.0 and $25.0. The current price of PLTR is up 4.73% at $14.6. Analysts from Goldman Sachs, Jefferies, B of A Securities, and Raymond James have maintained their ratings on Palantir, with price targets ranging from $10 to $18.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:49 pm

C

A significant investor has taken a bearish stance on Citigroup (NYSE:C), with 53% of recent trades being bearish and 46% bullish. The total amount for put options is $1,449,054 and for call options is $227,406. Whales have been targeting a price range from $40.0 to $55.0 for Citigroup over the last 3 months. B of A Securities maintains a Buy rating on Citigroup with a price target of $60, while RBC Capital and Morgan Stanley have downgraded their actions with price targets of $51 and $45 respectively.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:49 pm

LUV

Southwest Airlines Co (LUV) shares are trading higher by 3.82% to $35.30, potentially in sympathy with Delta Air Lines, which raised its Q2 and 2023 guidance. Delta anticipates revenue growth of 17%-18% for Q2 2023, up from the previous forecast of 15%-17%. For the full fiscal year 2023, the company now anticipates revenue growth of 17%-20%, up from the previous forecast of 15%-20%.

Portfolio Pulse from Henry Khederian

June 27, 2023 | 5:48 pm

HA

Hawaiian Holdings shares are trading higher in sympathy with Delta Air Lines after Delta raised its Q2 and 2023 guidance at its Investor Day presentation.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 5:38 pm